Catharina Svanborg Selected Research

Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)

1/2022	Immunomodulation therapy offers new molecular strategies to treat UTI.
1/2016	IRF7 inhibition prevents destructive innate immunity-A target for nonantibiotic therapy of bacterial infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catharina Svanborg Research Topics

Disease

41	Neoplasms (Cancer) 09/2022 - 01/2003
16	Infections 01/2018 - 02/2002
11	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 01/2003
7	Urinary Bladder Neoplasms (Bladder Cancer) 09/2022 - 09/2007
5	Inflammation (Inflammations) 09/2021 - 01/2003
4	Cystitis 01/2022 - 01/2012
4	Bacterial Infections (Bacterial Infection) 01/2022 - 02/2002
4	Pyelonephritis 01/2022 - 01/2005
4	Carcinoma (Carcinomatosis) 05/2015 - 12/2009
3	Glioblastoma (Glioblastoma Multiforme) 10/2012 - 03/2004
3	Papilloma (Papillomatosis) 10/2012 - 06/2004
3	Bacteriuria 02/2008 - 10/2005
3	Disease Susceptibility (Diathesis) 08/2007 - 01/2005
2	Pain (Aches) 01/2022 - 09/2021
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2014
1	Neuroinflammatory Diseases 09/2021
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 09/2021
1	Oncogene Addiction 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2016
1	Blister (Bulla) 11/2015
1	Spontaneous Abortion (Miscarriage) 02/2015
1	Hypertension (High Blood Pressure) 02/2015
1	Paralysis (Palsy) 06/2013
1	Osteosarcoma (Osteogenic Sarcoma) 01/2013
1	Human Influenza (Influenza) 09/2012

Drug/Important Bio-Agent (IBA)

35	Lactalbumin (alpha-Lactalbumin)IBA 01/2021 - 01/2003
22	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2003
18	Oleic Acid (Oleate)IBA 01/2021 - 12/2003
14	LipidsIBA 09/2022 - 01/2003
8	Virulence Factors (Pathogenicity Factors)IBA 01/2019 - 10/2005
6	Therapeutic UsesIBA 11/2020 - 03/2004
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2003
4	ChromatinIBA 05/2015 - 10/2003
4	Fatty Acids (Saturated Fatty Acids)IBA 06/2013 - 12/2003
4	Histones (Histone)IBA 12/2011 - 10/2003
3	SolutionsIBA 09/2022 - 05/2004
3	Small Interfering RNA (siRNA)IBA 01/2022 - 03/2011
3	Peptides (Polypeptides)IBA 01/2021 - 01/2012
3	Biological ProductsIBA 01/2014 - 02/2005
2	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 01/2022 - 01/2016
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2021 - 10/2016
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
2	InflammasomesIBA 10/2016 - 01/2016
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2015 - 01/2009
2	Ion Channels (Ion Channel)IBA 01/2014 - 01/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2013 - 08/2007
2	Lysine (L-Lysine)FDA Link 01/2013 - 04/2010
2	Histone Deacetylase InhibitorsIBA 12/2011 - 12/2007
2	CaspasesIBA 03/2011 - 01/2008
2	Toll-Like Receptor 4IBA 05/2010 - 08/2007
2	Caseins (Casein)FDA Link 12/2009 - 06/2006
2	CytokinesIBA 01/2009 - 02/2002
2	Interleukin-8 (Interleukin 8)IBA 09/2007 - 01/2005
2	LipopolysaccharidesIBA 07/2006 - 02/2002
2	apo-alpha-lactalbuminIBA 06/2006 - 12/2003
2	GlycoconjugatesIBA 05/2006 - 01/2003
1	Unilamellar LiposomesIBA 09/2022
1	Phosphatidylcholines (Phosphatidylcholine)IBA 09/2022
1	Lipid Bilayers (Lipid Bilayer)IBA 09/2022
1	Tissue ExtractsIBA 09/2022
1	Membrane LipidsIBA 09/2022
1	SphingomyelinsIBA 09/2022
1	Antimicrobial PeptidesIBA 01/2022
1	CathelicidinsIBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 09/2021
1	Interleukin-1 (Interleukin 1)IBA 09/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Protease La (Endopeptidase La)IBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 11/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020
1	Cyclin D1IBA 11/2020
1	Tumor Biomarkers (Tumor Markers)IBA 11/2020
1	LigandsIBA 01/2019
1	AntibodiesIBA 01/2019
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2019
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2018
1	Substance PIBA 01/2018
1	Amino Acids FDA Link 10/2016
1	Interleukin-1beta (Interleukin 1 beta)IBA 10/2016
1	Biomarkers (Surrogate Marker)IBA 10/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	GTP Phosphohydrolases (GTPases)IBA 11/2015
1	NucleotidesIBA 05/2015
1	Adenosine Triphosphate (ATP)IBA 05/2015
1	CateninsIBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2013
1	barium chloride (barium dichloride)IBA 01/2013
1	Amiloride (Midamor)FDA LinkGeneric 01/2013
1	InterferonsIBA 01/2013
1	Interferon Regulatory FactorsIBA 01/2013
1	Hemagglutinins (Hemagglutinin)IBA 09/2012
1	Glycoproteins (Glycoprotein)IBA 09/2012
1	Toxic ActionsIBA 04/2012

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2003
3	Intravesical Administration 11/2020 - 09/2007
2	Immunomodulation 01/2022 - 09/2021
2	Immunotherapy 10/2016 - 02/2016
2	Transplantation 02/2015 - 03/2004
1	Injections 09/2021
1	Intranasal Administration 09/2012